Recombinant multi-species UNC13B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UNC13B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is expressed in the kidney cortical epithelial cells and is upregulated by hyperglycemia. The encoded protein shares a high level of similarity to the rat homolog, and contains 3 C2 domains and a diacylglycerol-binding C1 domain. Hyperglycemia increases the levels of diacylglycerol, which has been shown to induce apoptosis in cells transfected with this gene and thus contribute to the renal cell complications of hyperglycemia. Studies in other species also indicate a role for this protein in the priming step of synaptic vesicle exocytosis. [provided by RefSeq, Jul 2008]
The Alternative Names of target: MUNC13,Munc13-1,Munc13-2,Munc13-2 (munc13),Protein unc-13 homolog B,UNC13,UNC13B,Unc13a,Unc13b,Unc13h1,Unc13h2,munc13-2
Go
to UNC13B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T53070-Ag-1/ GM-Tg-hg-T53070-Ag-2 | Human UNC13B protein | Human |
| GM-Tg-rg-T53070-Ag-1/ GM-Tg-rg-T53070-Ag-2 | Rat UNC13B protein | Rat |
| GM-Tg-mg-T53070-Ag-1/ GM-Tg-mg-T53070-Ag-2 | Mouse UNC13B protein | Mouse |
| GM-Tg-cynog-T53070-Ag-1/ GM-Tg-cynog-T53070-Ag-2 | Cynomolgus/Rhesus macaque UNC13B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T53070-Ag-1/ GM-Tg-felg-T53070-Ag-2 | Feline UNC13B protein | Feline |
| GM-Tg-cang-T53070-Ag-1/ GM-Tg-cang-T53070-Ag-2 | Canine UNC13B protein | Canine |
| GM-Tg-bovg-T53070-Ag-1/ GM-Tg-bovg-T53070-Ag-2 | Bovine UNC13B protein | Bovine |
| GM-Tg-equg-T53070-Ag-1/ GM-Tg-equg-T53070-Ag-2 | Equine UNC13B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T53070-Ag-1/ GM-Tg-hg-T53070-Ag-2;
GM-Tg-rg-T53070-Ag-1/ GM-Tg-rg-T53070-Ag-2;
GM-Tg-mg-T53070-Ag-1/ GM-Tg-mg-T53070-Ag-2; GM-Tg-cynog-T53070-Ag-1/ GM-Tg-cynog-T53070-Ag-2; GM-Tg-felg-T53070-Ag-1/ GM-Tg-felg-T53070-Ag-2; GM-Tg-cang-T53070-Ag-1/ GM-Tg-cang-T53070-Ag-2; GM-Tg-bovg-T53070-Ag-1/ GM-Tg-bovg-T53070-Ag-2; GM-Tg-equg-T53070-Ag-1/ GM-Tg-equg-T53070-Ag-2 |
| Products Name | UNC13B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | UNC13B |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UNC13B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.